1. Home
  2. FTFT vs SNSE Comparison

FTFT vs SNSE Comparison

Compare FTFT & SNSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FTFT
  • SNSE
  • Stock Information
  • Founded
  • FTFT N/A
  • SNSE 2005
  • Country
  • FTFT United States
  • SNSE United States
  • Employees
  • FTFT N/A
  • SNSE N/A
  • Industry
  • FTFT Business Services
  • SNSE Biotechnology: Pharmaceutical Preparations
  • Sector
  • FTFT Consumer Discretionary
  • SNSE Health Care
  • Exchange
  • FTFT Nasdaq
  • SNSE Nasdaq
  • Market Cap
  • FTFT 11.0M
  • SNSE 11.2M
  • IPO Year
  • FTFT N/A
  • SNSE 2021
  • Fundamental
  • Price
  • FTFT $2.36
  • SNSE $11.48
  • Analyst Decision
  • FTFT
  • SNSE Strong Buy
  • Analyst Count
  • FTFT 0
  • SNSE 4
  • Target Price
  • FTFT N/A
  • SNSE $72.50
  • AVG Volume (30 Days)
  • FTFT 481.0K
  • SNSE 5.2K
  • Earning Date
  • FTFT 11-18-2025
  • SNSE 11-13-2025
  • Dividend Yield
  • FTFT N/A
  • SNSE N/A
  • EPS Growth
  • FTFT N/A
  • SNSE N/A
  • EPS
  • FTFT N/A
  • SNSE N/A
  • Revenue
  • FTFT $2,368,206.00
  • SNSE N/A
  • Revenue This Year
  • FTFT N/A
  • SNSE N/A
  • Revenue Next Year
  • FTFT N/A
  • SNSE N/A
  • P/E Ratio
  • FTFT N/A
  • SNSE N/A
  • Revenue Growth
  • FTFT N/A
  • SNSE N/A
  • 52 Week Low
  • FTFT $1.01
  • SNSE $5.00
  • 52 Week High
  • FTFT $5.70
  • SNSE $17.40
  • Technical
  • Relative Strength Index (RSI)
  • FTFT 54.72
  • SNSE 73.13
  • Support Level
  • FTFT $2.10
  • SNSE $9.35
  • Resistance Level
  • FTFT $2.28
  • SNSE $10.00
  • Average True Range (ATR)
  • FTFT 0.17
  • SNSE 0.48
  • MACD
  • FTFT 0.01
  • SNSE 0.16
  • Stochastic Oscillator
  • FTFT 92.55
  • SNSE 100.00

About FTFT Future FinTech Group Inc.

Future FinTech Group Inc is engaged in the financial technology business. The company participates in supply chain financing services and trading in China, asset management business in Hong Kong, and cross-border money transfer services in the United Kingdom. It has also expanded into brokerage and investment banking business in Hong Kong and a cryptocurrency mining farm in the U.S. The company's reportable segments include asset management services, supply chain financing and trading, and others.

About SNSE Sensei Biotherapeutics Inc.

Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).

Share on Social Networks: